Deciphering the activation sequence of ferrociphenol anticancer drug candidates.
about
Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules.Oxidative metabolism of ferrocene analogues of tamoxifen: characterization and antiproliferative activities of the metabolites.Ferrocenyl Quinone Methide-Thiol Adducts as New Antiproliferative Agents: Synthesis, Metabolic Formation from Ferrociphenols, and Oxidative Transformation.Ferrocifen type anti cancer drugs.Inhibition of cancer derived cell lines proliferation by synthesized hydroxylated stilbenes and new ferrocenyl-stilbene analogs. Comparison with resveratrol.Quantitative analyses of ROS and RNS production in breast cancer cell lines incubated with ferrocifens.Ferrocenyl catechols: synthesis, oxidation chemistry and anti-proliferative effects on MDA-MB-231 breast cancer cells.ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.A new generation of ferrociphenols leads to a great diversity of reactive metabolites, and exhibits remarkable antiproliferative properties.Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides.Tamoxifen-like metallocifens target the thioredoxin system determining mitochondrial impairment leading to apoptosis in Jurkat cells.Oxidation-Responsive Polymers: Which Groups to Use, How to Make Them, What to Expect From Them (Biomedical Applications)Synthesis, Characterization, and Biological Properties of Osmium-Based Tamoxifen Derivatives - Comparison with Their Homologues in the Iron and Ruthenium SeriesReactive Oxygen Species Release, Alkylating Ability, and DNA Interactions of a Pterocarpanquinone: A Test Case for Electrochemistry
P2860
Q35105127-E026EEF3-F277-40AD-A090-FAEA61D5EDFBQ35604815-47546FD9-1248-486B-9CF9-8F9C7E531249Q36045117-5755C597-66E9-463E-9D1A-94A68A24AE33Q38612680-8F4C9AF8-65F4-4FA5-8FFC-A5FA3A0F2E6CQ38981537-46668FF3-3CD8-4622-86EF-B9A4AD28096DQ38997703-38ECDFA8-A018-4FC2-96F4-5037C8027082Q39346477-66D1D8F2-329A-4708-A4E8-D473845CBA76Q41815659-92854A74-1507-4943-8E5B-3333B8B6107AQ52599610-F8EC5754-CFA4-4AD1-B73C-1DB62F82A926Q53424633-0C0FF472-2AB6-4846-9419-E6B8D21E7B15Q53745075-3F59E0EF-03E5-427C-ABB6-8E1D290040E5Q57349516-52B839EC-AD6B-41B4-9E9C-1FE1DDCBAA19Q57391513-965F4545-517D-4789-88F6-79E8C6C12BC4Q58856158-11696E52-ABB4-4E4E-B2E5-B5F1AFF777EB
P2860
Deciphering the activation sequence of ferrociphenol anticancer drug candidates.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Deciphering the activation sequence of ferrociphenol anticancer drug candidates.
@en
Deciphering the activation sequence of ferrociphenol anticancer drug candidates.
@nl
type
label
Deciphering the activation sequence of ferrociphenol anticancer drug candidates.
@en
Deciphering the activation sequence of ferrociphenol anticancer drug candidates.
@nl
prefLabel
Deciphering the activation sequence of ferrociphenol anticancer drug candidates.
@en
Deciphering the activation sequence of ferrociphenol anticancer drug candidates.
@nl
P2093
P2860
P50
P356
P1476
Deciphering the activation sequence of ferrociphenol anticancer drug candidates
@en
P2093
Daniel Mansuy
Didier Hamels
Olivier Buriez
Pierluca Messina
Yves Michel Frapart
P2860
P304
P356
10.1002/CHEM.201103378
P407
P577
2012-04-11T00:00:00Z